Get started

Marijuana

Hyped cannabis stock ACB finally worth a buyAfter a long downward slide, Aurora Cannabis has finally hit a support critical level around $2.50. With the stock finally looking a little undervalued and a large recent earnings beat under its belt, ACB should rally higher. Call buyers are targeting $5.00 per share within two months, with over 40,000 call options located at that price. Cannabis is a hype sector, so when investor interest picks back up, it could quickly turn red hot. Several times in the last few years, ACB has hit over $10 per share.
ALong
by ChristopherCarrollSmith
10
$SBES In Breakout Mode Following Anticipation of $10 Bil MergerIt is anticipated that around 60% of the float is now locked and the rest to be locked by hedge funds and whales who will be coming in before the filings for the merger drops. The merging in candidate following all the DD is said to be RockySaaS, owned by $10 Bil Panshi Group. There is much much more DD in the iHub stickies than can be inputted here: investorshub.advfn.com Next resistance points are .0080, .015 and .02 after that it is pretty thin all the way up. Long term PT is around .10
OTC:SBESLong
by StockGuild
1
Cannabis Stocks Crash / Lawsuit Against HEXO Corp.A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against HEXO Corp. - HEXO According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) HEXO's reported inventory was misstated as the Company was failing to write down or write off obsolete product that no longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors; (3) HEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada; and (4) as a result, HEXO's public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. Disclaimer: We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and it is for entertainment purposes only.
H
by CryptoTrend-Alerts
1
AURORA CANNABIS (ACB) | Risky, But Probably Worth It!Hi, Aurora Cannabis Inc. produces and distributes medical cannabis products. Obviously, it has some mixed fundamentals but technically it may find some buyers around 2.00 - 2.50. Technical criteria are pretty strong, some of them are a bit subjective but in general, we have a strong crossing area. The green box consists of: 1) 2016 & 2017 high/resistance should start to work as a support level. 2) Actually, it has already started to act as support. In the last week, the price got a rejection upwards from the gray area (2016/17 high) and formed a Spinning Bottom candlestick pattern - bullish candlestick pattern. 3) Now, a bit subjective but still, channel projection worked as a support level and they make up a crossing area with the gray zone. 4) The crossing area becomes even stronger because we have D point exactly inside of it from the pattern called AB=CD 5) Fibonacci Extension 127% should make it (marked bounce area which stays between 2.00 - 2.50) also a bit stronger. 6) The current seasonal "pattern" favors buyers. It means that the end of the year has been pretty profitable for Aurora and the last upwards rally started about a year ago also in December. Target is up to you but the strongest resistance level stays around the 5.00 and if it reaches there from the current area then it will be 100%+ profit. Do your own research and please, take a second and support my effort by hitting the "LIKE" button, it is my only FEE from You! Best regards, Vaido
ALong
by VaidoVeek
6
Cannabis will reach the US... sooner than later!Recent significant events: House Passes Bill to Protect Banking for Marijuana Businesses Measure would prevent federal regulators from penalizing institutions that serve companies operating in states where cannabis is legal. // September 25th, 2019 House committee approves landmark bill legalizing marijuana at the federal level The House Judiciary Committee (Democratic-controlled) approved a bill that decriminalizes marijuana on the federal level, removing it from Schedule 1 of the Controlled Substances Act. The legislation, which passed 24 to 10, has a high chance of approval in the full House where Democrats control the chamber with 234 seats. It’s likely to face a tougher battle in the Republican-controlled Senate, where Majority Leader Mitch McConnell opposes marijuana legalization. // November 19th, 2019 There is no date for the senate to review the bill; we could see large volatility then. (will update asap) Technical analysis: Volume on the ladder of the events created the 3rd largest volume daily since MJ ETF was created (2016). 20SMA is our nearest resistance. --Keeping cannabis related stocks/ETFs closely watched.
AMEX:MJLong
by dorfmanmaster
GrowGeneration: Wrong-way cannabis earnings play of the dayGrowGeneration killed it on today's earnings report, but dropped about 5%. This presents a buying opportunity. The company reported GAAP earnings of $.03 per share, beating analyst estimates of $0.02/share. It reported revenue of $21.8 million, vs. the forecast of $20.621 million. These are big year-over-year increases. This time last year, the company reported a loss of ($.02) per share. Revenue is up $13.4 million, or 159% over last year's quarterly report of $8.400 million. The company raised its full-year revenue forecast to about $75M. Same-store sales and profit margins both saw large increases. Coming after analyst downgrades for Aurora Cannabis and CanopyGrowth, GrowGeneration's results make it a standout small-cap player in the ever-popular cannabis sector. Overall, this company is executing like a boss.
GLong
by ChristopherCarrollSmith
2
Massive Bounce off Major Support after Unnecessary Dump PT LT $3Photos of the newly built first dispensary from the company were posted and some people were not thrilled however they failed to do research on the clientele in the area which is why the building was built the way it was. In addition it is due to a developing segment of the county that should see massive growth in the next two years. Remember this is the first of many dispensaries to be built by the company. Looking to see new highs next week after investor confidence surged after midday today with a massive recovery on the candle.
OTC:SGDHLong
by StockGuild
$TOMI Back at Major Support After Name Change Delay Caused DumpAbsolutely nothing has changed with the company except with a delay at FINRA after the wrong person posted the information sent in for the name change of the R/M. I anticipate the same documents have been sent in with the right person already this time and awaiting the name change once again, which shouldn't take as long as last time, due to all the documents being required already being available for submission this time.
TLong
by StockGuild
IIPR: Innovative Industrial Properties The San Diego-based company is a real estate investment trust (REIT) specializing in properties used for growing and processing cannabis in U.S. states where medical marijuana is legal. While Innovative Industrial's stock has been dragged down over the last few months by sector weakness, the fast-growing company continues to post great quarterly numbers. In the second quarter, its revenue soared 155% year over year to $8.28 million, earnings per share (EPS) jumped 76% to $0.30, and adjusted funds from operations (FFO) per share -- a key profitability metric for REITs -- surged 90% to $0.59. Innovative Industrial Properties (NYSE:IIPR) is back to doing what it does best: purchase facilities that can be used to grow and process cannabis, lease them to state-licensed operators, and pass the profits on to investors. The real estate investment trust (REIT) completed a sale-leaseback deal with multistate dispensary company PharmaCann on Oct. 30. IIP paid $18 million plus transaction costs for a 48,000-square-foot industrial property in Dwight, Illinois. The REIT immediately entered into a triple-net lease with PharmaCann, which will continue to use the facility for cannabis cultivation and processing. IIPR will also reimburse PharmaCann for up to $7 million in tenant improvements. PharmaCann intends to use the funds to expand the property by about 18,000 square feet as it seeks to double its production capacity. The deal is the fifth time IIP has acquired a property from, and leased it back to, PharmaCann. Market Cap 845.75m Eneterprise Value 948.99 Way undervalued Dividend Yield 4.08% P/E FY 39x P/B 2.9x EPS 2020 79.4% YoY estimate. Price Target 140$ near 100% potential paying solid dividend. MACD showing bullish momentum BUY RSI breaking above downtrend line BUY EXANTE is a broker for professionals. Direct access to over 50 financial markets through one account. Stocks & ETFs, Currencies, Metals, Futures , Options, Funds, Bonds, Crypto¬currencies. Any information contained on this website is provided to you for informational purposes only and should not be regarded as an offer or solicitation of an offer to buy or sell any investments or related services that may be referenced here. Investing in certain instruments, including stocks, options, futures , foreign currencies, and bonds involve a high level of risk. Single trading account Trade in 50+ markets in the US, Europe and Asia — from your all-in-one multicurrency account on any device exante.eu
NYSE:IIPRLong
by EXANTE-TOG